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The simian virus 40 large T antigen is phosphorylated at eight or more sites that are clustered in an
amino-terminal region and a carboxy-terminal region of the protein. Mutants carrying exchanges at these
phosphorylation sites have been generated in vitro by bisulfite or oligonucleotide-directed mutagenesis and
analyzed for their phosphorylation patterns. Two-dimensional phosphopeptide analyses of the mutant large T
antigens confirmed most of the previously identified phosphorylation sites, namely, serine residues 106, 112,
123, 639, 677, and 679 and threonine residues 124 and 701. In addition, serine residue 120 was identified as a
new site, whereas serines residues 111 and 676 were excluded. Interestingly, several of the mutants exhibited
secondary effects in that a mutation in the amino-terminal region affected phosphorylation at distant and even
carboxy-terminal sites and vice versa. Thus, the amino- and carboxy-terminal domains appear to be in close
proximity in the three-dimensional structure of large T antigen. The possible consequences of the above
findings and the role of phosphorylation are discussed.
The simian virus 40 (SV40) large T antigen (LT) is a
phosphoprotein that displays various functions during lytic
infection and transformation (for reviews, see references 3,
8, and 37). It is involved in initiation and elongation of viral
DNA replication (50; reviewed in references 2 and 5) and
regulation of transcription of the viral genome. The functions
in replication are in part mediated by specific binding of LT
to control sequences at the origin of replication (9, 53, 55)
and in part through its intrinsic ATPase (56) and helicase (6,
49) activities and the interaction with the cellular DNA
polymerase a (48). Regulatory functions during transcription
also include DNA binding (9) and presumably interaction
with or modulation of cellular transcription factors (16, 31).
LT affects cellular DNA and RNA synthesis as well and is
capable of inducing malignant transformation (3). Transfor-
mation seems to require specific interaction with at least two
cellular proteins, p53 and the Rb protein (7, 27; for reviews,
see references 20 and 38).
Some of these functions seem to reside in distinct domains
of the LT molecule (3, 11, 33-35). In addition, LT exists in
various forms that differ in their subcellular distribution (3,
51), their degree of oligomerization (12, 21), and their
DNA-binding properties (13, 17, 41). Some of these sub-
classes appear to result from posttranslational modifications,
mainly phosphorylation (12, 21, 41, 54, 60). Additional
modifications include ADP ribosylation (18), glycosylation
(44), and fatty acid acylation (25).
Phosphorylation of LT occurs at eight or more sites that
are clustered between residues Ser-106 and Thr-124 in the
amino-terminal region and between residues Ser-639 and
Thr-701 in the carboxy-terminal region (26, 40, 57). Phos-
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phorylation takes place in a sequential manner in the cyto-
plasm and in the nucleus (43). Moreover, phosphorylation of
LT is reversible (10), and the individual phosphorylation
sites exhibit different turnover rates (39, 58). Recent studies
suggest that phosphorylation of LT modulates its activities
in DNA binding (23, 24, 30, 32, 42, 47) and replication (19,
30, 32) and, perhaps, the formation of oligomers (12, 21, 41)
and association with p53 (4). In particular, the phosphoryla-
tion state of some of the amino-terminal sites (Ser-123 and
Thr-124, which are close to the origin binding domain of LT
[1, 34, 46, 52]) strongly correlates with its DNA-binding
activity (24, 41). A role for the carboxy-terminal phosphor-
ylation sites is less evident. Viable deletion mutants lacking
some of those sites exhibit reduced DNA replication (35),
suggesting that phosphorylation of these sites, although not
essential, might exert some modulatory effect, too.
To acquire more insight into the functional roles of indi-
vidual phosphorylation sites, mutants were created in vitro
by using bisulfite (22) or oligonucleotide-directed mutagene-
sis (45). In this investigation we analyzed the phosphoryla-
tion patterns of these mutant LTs, first, to confirm previous
mapping data and, second, to analyze possible secondary
effects. Surprisingly, several mutants exhibited such effects
in that a mutation at an amino-terminal site affected phos-
phorylation at carboxy-terminal sites and vice versa. This
phenomenon suggests that the amino- and carboxy-terminal
domains are in close proximity in the three-dimensional
structure of LT.
MATERIALS AND METHODS
Cell lines and virus. The transformed rat cell lines C8, K5,
K6, W7, and D29 (derivatives of rat-1 cells [22]) and R106,
R111/112, R123, R124, R676, R677, R679, and R701 (deriv-
atives of rat-2 cells [45]) that had been transformed by the
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various LT mutants via Ca-phosphate transfection were
used as the source of the mutant LTs. For infections with
wild-type SV40 (strain 776 or VA 45-54), rat Fill or monkey
TC7 cells were used. Cells were grown on 9-cm plastic
dishes in Dulbecco modified Eagle medium supplemented
with 5% or, in some cases, 10% fetal calf serum (Boehringer,
Mannheim, Germany).
Labeling of cells. Metabolic labeling of cells was carried
out in deficient medium supplemented with dialyzed fetal
calf serum. 32p; was applied at 1 mCi per plate, and [14C]
glutamine was applied at 125 ,uCi per plate, in 1.5 ml of
medium for 4 h; radiochemicals were purchased from Am-
ersham.
Isolation of LT. Extracts from radiolabeled cells were
prepared essentially as described previously (40, 43); briefly,
cells were washed with cold phosphate-buffered saline and
lysed in isotonic lysis buffer (10 mM NaPO4 [pH 8], 140 mM
NaCl, 3 mM MgCl2, 1 mM dithiothreitol, 0.5% Nonidet P-40,
50 ,uM leupeptin [Sigma]); cellular residues were scraped off
the plate, nuclei were removed by low-speed centrifugation,
and the supernatant extract containing soluble cytoplasmic
and nucleoplasmic proteins was collected. Isolation of LT by
immunoprecipitation with hamster antitumor serum and
subsequent sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis were performed as described previously (40, 42).
Two-dimensional phosphopeptide analysis. Phosphopeptide
analysis was carried out as described previously (40).
Briefly, after sodium dodecyl sulfate-polyacrylamide gel
electrophoresis, LT was extracted from the gel, precipitated
with 20% trichloroacetic acid, oxidized with 3% performic
acid, and digested either with tolylsulfonyl phenylalanyl
chloromethyl ketone-trypsin (Worthington) alone or sequen-
tially with trypsin and pronase E (Merck, Darmstadt, Ger-
many). The digestion mixtures were separated on cellulose
thin-layer plates by electrophoresis and chromatography.
Electrophoresis was carried out at pH 1.9 (6% [vol/vol]
formic acid, 1.25% [vol/vol] acetic acid, 0.25% [vol/vol]
pyridine) at 1,000 to 1,300 V for 20 to 25 min. Ascending
chromatography was performed in isobutyric acid buffer
(isobutyric acid-pyridine-acetic acid-butanol-water [65:5:3:
2:29]) for 5 h. The phosphopeptides were visualized by
autoradiography with intensifying screens.
Phosphoamino acid analysis. Individual phosphopeptides
that had been separated as described above were localized
by autoradiography, eluted from the cellulose plates, and
hydrolyzed in 5.6 N hydrochloric acid at 105°C for 2 h in
sealed glass vials. The hydrolysis products were analyzed by
electrophoresis on cellulose thin-layer plates and autoradi-
ography as described previously (40).
RESULTS
Phosphorylation patterns of mutants in the amino-terminal
domain of SV40 LT. Figure 1 shows an assignment of the
phosphorylation sites of wild-type (wt) SV40 LT to individ-
ual phosphopeptides as previously determined (40-42) with
minor modifications, as stated in the legend to Fig. 1. These
phosphorylation sites have been mutated to get insight into
their biological and biochemical functions (22, 45). The
mutants and their phenotypes are listed in Table 1. Since
several of the mutants were replication defective, rat cell
lines that had been individually transformed with either one
of the mutants were used as a source for LT.
To rule out the possibility that the kinases that phosphor-
ylate LT have different specificities or activities in permis-
sive monkey and nonpermissive rodent cells, we first com-
pared the phosphopeptides of wt LT from infected monkey
TC7 and rat Flll cells. Cells were labeled with 32Pi, and LT
was isolated and subjected to two-dimensional peptide map-
ping as outlined in Materials and Methods. The phosphory-
lation patterns of LTs from the two sources were almost
identical (Fig. 1). Similar results were obtained with other rat
cell lines (data not shown). However, it should be noticed
that there are always minor variations, presumably due to
incomplete or alternate proteolysis.
The patterns obtained with the mutants in the amino-
terminal region of LT (Ser-106 to Thr-124) are shown in Fig.
2 and 3 in sequential order. The LT of mutant C8 (Ser-
106--Phe) (Fig. 2) lacked phosphopeptide 1, the position of
which is indicated by an arrow, which in wt LT contains the
phosphorylated Ser-106 (40). All other phosphopeptides
identified in wt LT were present. However, there were
additional quantitative differences from wt LT. The ratios
between peptides 7, 11, and 12 were drastically altered, and
peptide 2 was relatively weakly labeled compared with the
wt pattern (Fig. 1). As pointed out previously, peptides 7, 11,
and 12 reflect different phosphorylation states of the same
peptide; peptide 12 is phosphorylated at only one site
(Thr-124), and peptides 11 and 7 are phosphorylated at two
and three sites (Thr-124 and one and two of the neighboring
serine residues), respectively (41; see below). Thus, the
lower abundance of peptides 7 and 11 relative to peptide 12
indicated inefficient phosphorylation of the respective serine
residues in the C8 mutant. Moreover, the low intensity of
peptide 2, which is phosphorylated at Ser-639, suggested
that the mutation exerted some effect on phosphorylation in
the carboxy-terminal domain. On the other hand, when
mutant SV106, in which Ser-106 was replaced by Ala, was
analyzed the same way, no such secondary effects were
observed (Fig. 2), suggesting that not the lack of phosphor-
ylation at Ser-106 but rather the introduction of the bulky
Phe residue was responsible for the effects seen with C8.
In our previous studies, it remained unclear whether
Ser-111 or Ser-112 or both were phosphorylated. The mu-
tants K5 and K6 carrying mutations at the respective resi-
dues served to clarify this question. Mutant K5 (Ser-
111->Phe) (Fig. 2) lacked peptide 6, as expected, since this
peptide contains Ser-111 and probably Ser-112 in wt LT (40).
Instead, a prominent peptide designated 6a appeared on the
left of peptide 7. We assume that this peptide represents an
altered form of peptide 6 and that its different mobility during
electrophoresis and chromatography results from the muta-
tion of Ser-111 to a hydrophobic residue. Consequently,
peptide 6a (and its counterpart in wt LT) must be phosphor-
ylated at Ser-112. It should be pointed out that in this and all
other cases in which peptides migrated off their normal
position on the thin-layer plates, mixed peptide analyses of
wt and mutant LTs were performed to exclude any abnor-
malities during the experimental procedure (data not
shown). Mutant K5 also exhibited a slight overrepresenta-
tion of peptide 12, whereas peptide 2 was relatively weakly
labeled and peptide 1 was not detectible. The other phos-
phopeptides appeared with the usual intensities.
When the mutant K6 (Ser-112--Asn) was analyzed (Fig.
2), peptide 6 was also missing, but there was no new peptide
instead and the overall pattern was maintained. Similarly,
LT carrying a double mutation of Ser-111 and Ser-112 to Ala
and Cys, respectively, exhibited a rather normal phosphor-
ylation pattern except for the lack of peptide 6 and a slight
overrepresentation of peptide 12 (data not shown). These
results strongly suggest that in wt LT, Ser-112 but not
Ser-111 is phosphorylated. However, other interpretations
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FIG. 1. Comparison of phosphopeptides of SV40 LT from monkey and rat cells and assignment of phosphorylation sites. Monkey TC7 or
rat Flll cells were infected with wt SV40. Two days postinfection cells were labeled with 32Pi for 3 h, and LT was isolated byimmunoprecipitation and sodium dodecyl sulfate-polyacrylamide gel electrophoresis and processed for two-dimensional peptide mapping as
described previously (41). Electrophoresis was done in the horizontal direction, and chromatography was in the vertical direction (41); the
vertical dash indicates the origin. The phosphopeptides were visualized by autoradiography with intensifying screens. The nomenclature
refers to that in reference 41. However, it should be noticed that peptide 1, which is sometimes barely visible and which had been erroneously
assigned to peptide 6' in previous publications (39, 41, 43), has now been reassigned. Peptides 6 and 6' obviously represent two forms of the
same or overlapping peptides with varying relative abundance. Peptide "x" on the phosphopeptide map from Flll cells appeared to be
characteristic of rat cells because it was never observed in monkey cells. Its nature has not been investigated. The scheme at the bottom
shows the location of the phosphorylation sites within the linear arrangement of the LT polypeptide chain. The relative metabolic stabilities
of individual phosphate residues (39) are also indicated. The list on the right shows which phosphorylation sites are represented by the
individual phosphopeptides (40, 41; this study).
are also possible, e.g., it cannot be ruled out that in wt LT,
both Ser-111 and Ser-112 are phosphorylated and that the
mutation at Ser-112 prevents phosphorylation at both resi-
dues, whereas the mutation at Ser-111 still allows phosphor-
ylation of Ser-112 (see Discussion).
Identification of Ser-120 as a new phosphorylation site.
Analysis of the following set of mutants carrying mutations
at Ser-120, Ser-123, and Thr-124 revealed some unexpected
results that were only partly compatible with previous map-
ping data. Ser-123 and Thr-124 had been identified as phos-
phorylated residues in peptides 7, 11, and 12, whereas
Ser-120 had been excluded (40, 41). This conclusion was
derived from the amino acid composition of these peptides,
as determined by differential amino acid labeling. The amino
acid sequence in this region is Thr-117-Ala-Asp-Ser-120-Gln-
His-Ser-123-Thr-124-Pro-Pro-Lys-127 (14, 36). We found
proline and lysine in peptide 7 and proline, lysine, and
histidine in peptide 11 (40). The relationship of peptide 12 to
peptides 7 and 11 was revealed in subsequent studies (41).
Since glutamine had not been detected, Ser-120 was thought
to be absent from these peptides. Their different charges and
polarities had been ascribed in part to differential phosphor-
ylation and in part to the absence of histidine in peptide 7
(the absence of a positively charged histidine would have an
effect on the electrophoretic mobility similar to that of the
presence of an additional phosphate residue). Based on this
interpretation, one can predict the phosphorylation patterns
of the mutants in this region.
The double mutant W7 with exchanges of His-122 and
Ser-123 to Tyr and Phe, respectively should reveal the
absence of peptides 7, 11, and 12 and the appearance of only
one new peptide, since there should be only one phosphor-
ylatable residue (Thr-124) and the replacement of His would
extinguish possible effects of this residue. Indeed, mutant
W7 revealed the absence of peptides 7, 11, and 12 (Fig. 3).
However, two new peptides appeared instead. Assuming
that these represented altered forms of peptides 11 and 12,
they were designated lla and 12a, respectively. Their mi-
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TABLE 1. Phosphorylation site mutants of SV40 LT and their properties
Mutant Exchange Viability replication binding Transformation'(%) replication
~~Site I Site II
C8 Ser-106--Phe - + + Def
SV106 Ser-106--Ala + + + + +
KS Ser-111-->Phe + + NTb NT +
K6 Ser-112-->Asn + + NT NT +
SV111/112 Ser-111--*Ala, Ser-112-->Cys + (44) + + + +
SV120 Ser-120---Ala _ +C + + +
W7 His-122-*Tyr, Ser-123--)Phe - - + + +
SV123 Ser-123-->Ala - +C + + +
D29 Thr-124--*Ile - + + +
SV124 Thr-124--1Ala - + - +
SV639 Ser-639--*Ala + (59) + + + ++d
SV676 Ser-676-->Ala + (48) + + + ++d
SV677 Ser-677-->Ala + (67) + - + Def
SV679 Ser-679--+Ala + (70) +e + +e Def
SV701 Thr-701--*Ala + (78) + + + +
a Def, Mutants were transformation defective in that they induced transformed foci with reduced frequency (approximately 10% [C8 and SV677] or 36%
[SV6791 of the wt value) and after longer latency periods (22, 45).
b NT, Not tested.
c SV40 DNA replication occurs, but at a very low level and with altered kinetics (58a).
d Transformation is enhanced approximately twofold.
e Site II binding and DNA replication are higher than with wt LT.
gration was compatible with the absence of a positively
charged histidine and the exchange to hydrophobic residues.
To confirm this interpretation, the altered peptides were
eluted from the cellulose plate and subjected to phosphoam-
ino acid analysis (data not shown). Peptide 12a was phos-
phorylated at threonine, as expected, but peptide lla con-
tained both phosphothreonine and phosphoserine. Since
Ser-123 was mutated, we assumed that in this mutant Ser-
120 might be phosphorylated instead. This unexpected result
could be a consequence of the mutation, resulting in both
altered phosphorylation and altered proteolytic cleavage. In
addition to these effects, the W7 mutant LT exhibited
reduced phosphorylation of all sites, including Thr-701 (in
peptide 13). This latter effect was probably due to partial
degradation of LT before or during extraction, whereby the
carboxy terminus is specifically removed (unpublished ob-
servation), indicating that W7 LT was more sensitive than wt
LT to proteases.
We next analyzed mutant SV123, which bears a more
subtle exchange of Ala for Ser-123. The overall phosphory-
lation pattern was roughly maintained in SV123, except that
peptide 7 was missing and two prominent peptides appeared
that migrated slightly off the positions of peptides 11 and 12,
as determined in mixed peptide analyses (Fig. 3). They were
designated llb and 12b, to distinguish them from the corre-
sponding peptides of W7. Phosphoamino acid analysis of
peptide 12b revealed only .phosphothreonine, as expected.
But again, peptide llb contained both phosphoserine and
threonine, suggesting that in this mutant, too, Ser-120 was
phosphorylated. Peptide llb migrated sometimes as a dou-
blet; the difference between the two variants remains un-
clear, however. Additional quantitative changes included
overrepresentation of peptide 6 and reduced labeling of
peptides 9 and 10, indicating effects on distant sites.
To further clarify the above findings, mutant SV120,
carrying an exchange of Ala for Ser-120, was investigated.
Based on our previous interpretations, this mutation should
not have any effects on the overall phosphorylation pattern,
unless it caused conformational alterations. However, phos-
phopeptides 7, 11, and 12 were absent (Fig. 3). Instead, three
prominent peptides appeared that migrated farther to the
cathode and farther up during chromatography. Surpris-
ingly, these were all phosphorylated only at threonine, as
revealed by acid hydrolysis. Thus, they were designated 12c,
12c', and 12c", to indicate their presumptive relationship to
peptide 12. Mixed peptide analysis of SV120 and wt LT (Fig.
3) showed that peptide 12c' migrated slightly off the position
of peptide 12, suggesting that peptide 12c' contained the
mutated residue 120. Thus, we concluded that peptide 12 in
wt LT does also contain residue 120. Peptides 12c and 12c"
were probably generated by alternative proteolytic cleavage,
a phenomenon that was reproducibly observed in cases
where peptide 12 was overrepresented, in other words,
where Ser-123, Ser-120, or both were underphosphorylated
(for comparison, see the peptide maps of mutants C8 [Fig. 2]
and SV677 [see Fig. 7]).
It was surprising that there was no peptide corresponding
to peptide 11, which was phosphorylated on Thr-124 and
Ser-123. This finding can be explained in two ways. Either
Ser-120 and not Ser-123 is the phosphorylated residue in
peptides 7 and 11 or both Ser-120 and Ser-123 can be
differentially phosphorylated (one of them in peptide 11 and
both in peptide 7). In the latter case, the mutation at Ser-120
would prevent phosphorylation at Ser-123, whereas the
mutation at Ser-123 would not affect phosphorylation at
Ser-120, as revealed from mutants W7 and SV123. In both
cases, however, peptides 7, 11, and 12 should contain
glutamine, which we did not detect in previous analyses (40).
The apparent discrepancies with previous results and
conclusions led us to reinvestigate the composition and
phosphorylation state of peptides 7, 11, and 12. Labeling of
wt LT with [14C]glutamine and mixed peptide analyses with
32P-labeled LT (40) revealed a weak Gln signal in peptides 11
and 12 (Fig. 4), whereas in peptide 7 it was hardly detectable,
probably due to the lower abundance of the latter peptide.
To determine more precisely the relative amounts of
phosphoserine and phosphothreonine in these peptides, they
were isolated and subjected to phosphoamino acid analysis
(Fig. 5). Peptide 12 revealed only phosphothreonine, and
peptides 11 and 7 gave rise to phosphothreonine and phos-
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FIG. 2. Phosphopeptide analysis of LT mutants with mutations at Ser-106, Ser-111, and Ser-112. Rat cells transformed with mutants C8,
SV106, K5, and K6 (Table 1) were labeled with 32p, and the mutant LTs were isolated and analyzed as described in the legend to Fig. 1 for
wt LT. The arrows point to the positions of phosphopeptides that are missing and that represent the mutated phosphorylation sites.
phoserine at ratios of 1:3 and 1:6, respectively. Thus peptide
7 contained twice the amount of phosphoserine label as
peptide 11. The discrepancy with the expected ratios of 1:1
and 1:2 resulted probably in part from incomplete hydrolysis
of the threonine-proline bonds (see sequence of the peptides
above), since there was always some uncleaved material
remaining at the origin during electrophoresis. Conse-
quently, phosphothreonine would be underrepresented. In
addition, the threonine phosphate has a lower turnover than
the serine phosphates (39), resulting in different amounts of
32p incorporation during a 4-h labeling period.
In an additional analysis, the isolated peptides 7, 11, and
12 were subjected to partial acid hydrolysis in 6 N hydro-
chloric acid at 37°C for 20 h as described previously (40), and
the products were analysed by peptide mapping. Each
peptide gave rise to an individual pattern (Fig. 6). Peptides 7
and 11 gave rise to six products, designated p through u, four
of which were identical (Fig. 6a and b, respectively). Peptide
12 (Fig. 6c) revealed only one phosphorylated product. The
precise relationship to the other peptide fragments deriving
from peptides 7 and 11 could not be determined, but we
assume that the cleavage product of peptide 12 is identical to
peptide r or s. Taken together, these results strongly sug-
gested that in wt LT both Ser-123 and Ser-120 are phosphor-
ylated, in a differential manner.
The analyses of mutants with exchanges at Thr-124 re-
vealed the expected results with respect to peptides 7, 11,
and 12. Mutant D29 (Thr-124-Ile) revealed the absence of
peptides 7, 11, and 12 (Fig. 3). Instead, two new peptides,
designated lld and 12d, appeared. These were phosphory-
lated exclusively at serine residues, suggesting that they
represented the altered forms of peptides 11 and 12, being
phosphorylated either at both Ser-120 and Ser-123 or only at
Ser-120 or Ser-123, respectively. Additional alterations in-
cluded relatively low intensities of peptides 2, 9, 10, and 13,
deriving from the carboxy-terminal region and overrepresen-
tation of peptide 6. Thus, this mutation seemed to have a
rather strong effect on phosphorylation of the carboxy-
terminal sites. Mutant SV124 (Thr-124--+Ala) showed a
rather normal peptide pattern (Fig. 3, panel SV124), except
that peptide 1 was overrepresented and peptide 7 was
missing. Peptides lle and 12e, which migrated close to the
positions of the authentic peptides 11 and 12, contained only
phosphoserine, as expected. These latter results confirmed
that in wt LT, Thr-124 is phosphorylated in these peptides.
Mutants in the carboxy-terminal domain. Five mutants in
the carboxy-terminal domain carrying exchanges at Ser-639,
Ser-676, Ser-677, Ser-679, and Thr-701 into Ala (45) were
analyzed for alterations in their phosphorylation patterns as
above. Mutant SV639 showed a normal phosphopeptide
pattern, except that peptide 2, which in wt LT carries the
phosphorylated Ser-639, was missing (data not shown).
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FIG. 3. Phosphorylation patterns of LT mutants carrying mutations at Ser-123, Ser-120, and Thr-124. 32P-labeled LT was isolated from
cells transformed with mutants W7, SV123, SV120, D29, and SV124 (Table 1) and analyzed as described in the legend to Fig. 1. SV120+wt
represents a mixture of phosphopeptides derived from SV120 and wt LT, to demonstrate the relative locations of peptides 12c.
Mutations at residues Ser-676, Ser-677, and Ser-679
served to clarify which of these serines are phosphorylated.
Mutant SV676 exhibited a normal peptide pattern (data not
shown), indicating that in wt LT Ser-676 is not phosphory-
lated. In contrast, mutant SV677 revealed the lack of pro-
nase peptides 8, 9, and 10 and peptides designated "x,"
which are probably related to the former (Fig. 7). Thus we
conclude that Ser-677 is phosphorylated in wt LT. Surpris-
ingly, the mutation at Ser-677 led also to drastic changes in
the amino-terminal domain; phosphopeptides 7 and 11 were
hardly detectable, but peptides 12 and 6 were overrepre-
sented. Thus, this mutant represented a counterpart of some
of the amino-terminal mutants, which affected phosphoryla-
tion in the carboxy-terminal domain. Interestingly, the pro-
nase peptides 12c and 12c" observed on the peptide map of
SV120 (Fig. 3) were also present in relatively high amounts,
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FIG. 4. Analysis of phosphopeptides of wt LT for the presence
of glutamine. SV40-infected TC7 cells were labeled with [14C]glu-
tamine, and LT was isolated and processed for peptide mapping as
described for the phosphopeptides in the legend to Fig. 1. Samples
were run on TL cellulose plates with and without 32P-labeled
peptides to localize comigrating peptides. The peptide maps were
exposed to X-ray film before and after decay of the 32P label. In
panel a, the locations of the phosphopeptides are indicated by
circles. In panel b, the positions of phosphopeptides 7, 11, and 12
are indicated by arrows.
supporting the above-mentioned assumption that lack of
phosphorylation at Ser-120 or Ser-123 leads to altered cleav-
age by pronase.
LT encoded by SV679 revealed a rather normal pattern of
pronase peptides, except that peptides in the center of the
map seemed to be lacking, as indicated by arrows, and
peptide 1 was hardly detectible (Fig. 7). Thus, it cannot be
concluded with certainty that Ser-679 is phosphorylated in
wt LT. However, there were additional changes in that this
mutant, too, exhibited a slight overrepresentation of pep-
tides 11 and 12, although not to the same extent as that in
mutant SV677.
In mutant SV701, carrying a Thr-701--*Ala exchange,
phosphopeptide 13 was missing, as expected (Fig. 7). Again,
peptide 12 was overrepresented, indicating an effect on
amino-terminal sites too. In addition, peptides 1 and 2 were
only weakly labeled.
P-Ser P-Thr ori
' ~~~~11
12
FIG. 5. Phosphoamino acid analysis of peptides 7, 11, and 12.
Phosphopeptides were separated on TL cellulose plates, localized
by autoradiography, eluted, and hydrolyzed as described in the text.
Phosphoamino acids were separated on TL cellulose plates by
electrophoresis at 1,000 V for 60 mm in the presence of unlabeled
phosphoserine and phosphothreonine.
Taken together, these analyses confirmed most of the
phosphorylation sites that had been determined previously:
serine residues 106, 112, 123, 639, 677, and perhaps 679, and
threonine residues 124 and 701. Ser-120 was identified as a
new site. On the other hand, Ser-1il and Ser-676 were
excluded. Based on the overall effects of a given mutation,
the mutants fell into two classes: those affecting only the
mutated site and those showing secondary effects on phos-
phorylation of distant sites. This latter observation indicates
that the two phosphorylation domains, which are more than
500 residues apart in the primary sequence, interact with
each other, perhaps due to their close proximity in the
three-dimensional structure of the LT molecule.
DISCUSSION
Reevaluation of phosphorylation sites of LT. The phosphor-
ylation sites of SV40 LT, as previously identified (26,40, 57),
had been mutated to investigate their biological role (22, 45).
In the present investigation, we analyzed the phosphoryla-
tion patters of these mutant LTs; first, to confirm previous
assignments of the phosphorylation sites and, second, to
investigate possible secondary effects of the mutations, i.e.,
structural alterations, that might be reflected by altered
phosphorylation patterns. Indeed, the phosphopeptide anal-
yses revealed two categories of mutants. Mutants of the first
category lacked only phosphopeptides in which the phos-
phorylation site was mutated. Mutants of the second cate-
gory showed additional alterations in that phosphorylation at
distant sites was affected.
The phosphopeptide pattern obtained from mutants C8,
SV106, SV111/112, D29, SV124, SV639, and SV701 were
compatible with previous mapping data in that they lacked
the peptides to which we had assigned Ser-106, Ser-111 or
Ser-112, Thr-124, Ser-639, and Thr-701, thus confirming
these residues as phosphorylation sites in wt LT (40, 42). In
the cases of Seine residues 111 and 112 in the amino-
terminal region and seine residues 676, 677, and 679 in the
carboxy-terminal region, it remained unclear which and how
many of these residues were phosphorylated. Mutants K5,
K6, SV676, SV677, and sV679 served to clarify this ques-
tion. Mutants K5 and K6, carrying mutations at Ser-111 and
VOL. 65, 1991 1485
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FIG. 6. Analysis of phosphopeptides 7, 11, and 12 by partial acid
hydrolysis. Phosphopeptides were isolated as described in the
legend to Fig. 5 and subjected to partial acid hydrolysis in 6 N HCI
at 37°C for 20 h (41). The fragments obtained were analyzed by
two-dimensional peptide mapping as described before for the
trypsin-pronase peptides: a, cleavage products of peptide 7; b,
products of peptide 11; c, product of peptide 12. The peptide
fragment in panel c was not marked because its precise relationship
to the fragments in panels a and b could not be determined.
Ser-112, respectively, both lacked phosphopeptide 6, to
which we had assigned these residues (40). However, KS
gave rise to a new phosphopeptide that must be phosphory-
lated at Ser-112, whereas K6 did not. Thus, the simplest
interpretation of the data is that in wt LT only Ser-112 but
not Ser-111 is phosphorylated. The physical properties of the
altered peptide 6 (6a in Fig. 2) are compatible with the
exchange of the polar serine to the hydrophobic phenylala-
nine residue. However, we cannot completely rule out the
more complex interpretation that in wt LT, Ser-ill or even
both Ser-111 and Ser-112 are phosphorylated and that the
mutation at Ser-111 allows or leads to alternative phosphor-
ylation of Ser-112, whereas the mutation of Ser-112 prevents
phosphorylation at residue 111.
The serine residues 676, 677, and 679 have been assigned
to two overlapping tryptic peptides (5 and 5' [40]). Cleavage
SV701
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FIG. 7. Phosphopeptide analysis of LT mutants in the carboxy-
terminal region. Mutant SV677, SV679, and SV701 LTs were
isolated from the respective transformed cell lines and subjected to
peptide mapping as described in the legend to Fig. 1.
by pronase of the tryptic peptide 5' gave rise to pronase
peptides 9 and 10, whereas cleavage of the more negatively
charged tryptic peptide 5 revealed a more complex pattern
including pronase peptides 2, 8, 9, and 10 (40). The hetero-
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geneity of these peptides and their interrelationships
strongly suggested that at least two of the above residues are
phosphorylated. The phosphopeptide pattern of mutant
SV676 was indistinguishable from that of wt LT, indicating
that Ser-676 is not phosphorylated. Mutant SV677 clearly
lacked peptides 8, 9, and 10 (and the tryptic peptides 5 and
5a; data not shown), thus strongly suggesting that in wt LT
Ser-677 is, indeed, phosphorylated. The results with mutant
SV679 were less clear cut, since only peptides designated
"8" were missing or reduced, whereas all other peptides
appeared to be present. Our previous analyses suggested
that the phosphorylated residue in peptide 8 differs from that
in peptides 9 and 10 (40). Since the latter two peptides seem
to be phosphorylated only at Ser-677 (see above), Ser-679
appears to be the phosphorylated residue in peptide 8. The
lack of peptide 8 in mutant SV677 may be actually a
secondary effect in that this mutation prevents phosphory-
lation at Ser-679. Thus, we assume but have no clearcut
evidence that both Ser-677 and Ser-679 are phosphorylated
in wt LT. Interestingly, mutants SV677 and SV679 have
similar phenotypes with respect to viability and transforming
capacity but are quite different in DNA binding and replica-
tion. The LT of SV677 does not bind site I but exhibits
normal site II binding and replication. On the other hand,
mutant SV679 is even more active in site II binding and DNA
replication than wt LT (45) (Table 1). These properties
suggest that both Ser-677 and Ser-679 play a regulatory role
and are subject to reversible phosphorylation.
Identification of Ser-120 as an additional phosphorylation
site. In previous studies, we had determined that Ser-123 and
Thr-124 are differentially phosphorylated in pronase pep-
tides 7, 11, and 12 (40, 41), whereas Ser-120 had been
excluded, as described in Results. However, Ser-123 mu-
tants retained a phosphorylated serine in the respective
peptides, whereas the Ser-120 mutant did not. One possible
interpretation of these results is that the mutation at Ser-123
leads to alternative phosphorylation of Ser-120, whereas the
mutation at Ser-120 would prevent phosphorylation of Ser-
123. An alternative possibility is that in wt LT Ser-120 but
not Ser-123 is phosphorylated. The detection of glutamine in
peptides 7, 11, and 12 means that Ser-120 can no longer be
excluded. However, the following findings strongly suggest
that both Ser-120 and Ser-123 can be phosphorylated. (i) The
three peptides migrate on a diagonal, indicating that they
differ from each other by the same degree of charge and
polarity, which is compatible with their being phosphory-
lated at one (peptide 12), two (peptide 11), or three (peptide
7) residues. (ii) Peptides 11 and 7, indeed, showed increasing
amounts of phosphoserine relative to phosphothreonine. (iii)
Partial acid hydrolysis of the isolated peptides 7, 11, and 12
revealed different phosphorylated cleavage products for
each peptide. (iv) When we treated wt LT with increasing
amounts of the catalytic subunit of protein phosphatase 2A,
we found a sequential conversion of peptide 7 to 11 and then
to 12; the resistant phosphate in peptide 12 was linked to
threonine, indicating successive dephosphorylation of the
two serine residues (43a, 59). (v) Finally, the SV120 mutant
exhibits functional defects similar to those of SV123 (45).
Thus, peptides 7, 11, and 12 reflect three different phosphor-
ylation states of LT; peptide 12 is phosphorylated only at
Thr-124, and peptides 11 and 7 are phosphorylated at Thr-
124 and one and two of the adjacent serine residues, respec-
tively. At present, we cannot distinguish whether peptide 11,
which represents the intermediate state, is phosphorylated at
one specific serine residue or randomly at either Ser-120 or
Ser-123. However, the finding that the mutation at Ser-120
obviously prevented phosphorylation of Ser-123 suggests
that phosphorylation of Ser-120 is a prerequisite for phos-
phorylation of Ser-123. Thus, peptide 11 may be phosphor-
ylated at Ser-120 rather than Ser-123.
In summary, our analyses confirmed the previously iden-
tified serine residues 106, 112, 123, 639, 677, and presumably
679 and threonine residues 124 and 701 as phosphorylated
residues; Ser-676 and, presumably, Ser-ill were excluded,
whereas Ser-120 was identified as a new phosphorylation
site. It should be pointed out that this and previous studies
dealt only with phosphopeptides that are clearly and repro-
ducibly detected. There are always minor peptides that
might be either alternative cleavage products generated
during proteolytic digestion or might represent additional
phosphorylation sites that are modified only in a particular
subfraction of LT. For example, peptide 12 is usually barely
detectible in bulk LT preparations but becomes a prominent
peptide in the monomeric or DNA-binding fraction of LT
(41).
Effects of mutations on distant phosphorylation sites. Sev-
eral mutations showed more or less pronounced effects on
distant phosphorylation sites. The mutation of Ser-120->Ala
seemed to prevent phosphorylation of Ser-123. The muta-
tions in C8 (Ser-106->Phe) and, to a lesser extent, KS
(Ser-111--lPhe) led to reduced phosphorylation of Ser-120
and Ser-123 in the amino-terminal region and even Ser-639 in
the carboxy-terminal region. Similarly, the mutations in W7
and D29 showed an effect on carboxy-terminal sites. On the
other hand, mutations at Ser-677, Ser-679, and Thr-701
exhibited an influence on sites in the amino-terminal domain;
the most pronounced effect was seen with mutant SV677, in
which phosphorylation of Ser-120 and Ser-123 was drasti-
cally reduced and that of Ser-112 seemed to be enhanced. In
one case (SV124), peptide 1, representing Ser-106, was more
heavily labeled than usual.
Short-range effects could be due to the mutation per se or
to the lack of phosphorylation of a particular site. In the case
of C8 and K5, the mutations to the bulky and hydrophobic
phenylalanine seem to be responsible for these effects, since
the mutants SV106 and SV111/112 (Ser->Ala) exhibited
rather normal phosphorylation patterns. The phenylalanine
residue may cause structural distortions and thus alter the
accessibility of some sites for the respective kinases or
phosphatases.
The secondary effects seen with SV120 and SV677 are
probably due to the lack of phosphorylation of these sites:
first, because the changes of;Ser->Ala are rather subtle and,
second, because the mutations at adjacent residues (Ser-123
or Ser-676) did not reveal similar effects. The prevention of
phosphorylation of Ser-123 in SV120 suggests that the phos-
phorylation of Ser-120 might serve as a recognition signal for
subsequent phosphorylation of Ser-123.
The long-range effects of amino-terminal mutations on
carboxy-terminal sites and vice versa suggest that the two
phosphorylation domains might be in close proximity in the
three-dimensional structure of LT. As a result, changes in
one domain could induce structural alterations in the other.
The drastic reduction of phosphorylation in the amino-
terminal region seen with mutant SV677 is especially inter-
esting. First, it suggests that Ser-677 must be phosphorylated
in order to achieve phosphorylation of Ser-120 and Ser-123.
However, it is unlikely that phosphorylation of Ser-677 is a
direct recognition signal for the kinase(s) that phosphory-
lates Ser-120 and Ser-123. Rather, we assume that phosphor-
ylation of Ser-677 induces structural changes in the amino-
terminal domain, which might lead to exposure of the
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FIG. 8. Model indicating the major interactions between phosphorylation sites in the two phosphorylation domains. The upper line
represents LT, divided into the two domains that are encoded by the two exons. The regions containing the phosphorylation sites are shown
enlarged with the amino acid sequence in the one-letter code. Phosphorylation sites, as confirmed or determined (for Ser-120) in the present
study, are indicated by encircled P's. Arrows between phosphorylation sites indicate an influence of individual phosphorylation events on
distant sites, as concluded from the present results: ( ) negative effects, (- - -) enhancing effect. Minor or less pronounced effects were
not included.
phosphorylation sites. This view is supported by other
findings: oligomerization of LT seems to induce (or require)
conformational changes, and the cellular proteins p53 and
Rb associate only with the oligomeric form of LT (4, 28, 29).
Moreover, antibodies against phosphorylation sites induced
by corresponding synthetic peptides show a remarkable
preference for the tetrameric form of LT (15). Interestingly,
SV677-encoded LT is defective for oligomerization (39a),
perhaps because it is incapable of inducing the appropriate
conformational changes. The major interactions of individ-
ual phosphorylation sites and their influence on each other,
as deduced from these data, are depicted in Fig. 8.
Correlation with functional defects: role of individual phos-
phorylation sites in DNA binding. Previous studies suggested
that the phosphorylation state of the neighboring residues
Ser-123 and Thr-124 might be important for the DNA-
binding activity of LT (24, 41). Phosphorylation at Thr-124
seems to be required for site II DNA binding (30), whereas
phosphorylation at Ser-123, and presumably the newly iden-
tified Ser-120, appears to have a modulatory effect by
decreasing the affinity or activity of binding (24, 32, 41),
particularly to site 11 (24, 32). Consistent with this view is the
high turnover in vivo of these serine sites (39). Furthermore,
all mutants with exchanges at Ser-123, Thr-124, and Ser-120
exhibited functional defects, either in DNA binding or rep-
lication (22, 45) (Table 1). Mutant SV124 bound exclusively
to binding site I, whereas mutants SV106, SV120, and SV123
bound better to binding site II than did wt LT (45), thus
providing additional support for the above concept. The
functional defects of other mutants, C8 and SV677, were
unexpected. C8 LT bound to origin sequences but was
replication defective (22, 34). The LT of mutant SV677 did
not bind to site I but bound very efficiently to site II, as did
SV679 LT (45). Since the ori-binding domain of LT has been
mapped in the amino-terminal third of the molecule (1, 22,
34, 46, 52), it is unlikely that the carboxy-terminal phosphor-
ylation domain excerts a direct effect on DNA binding.
Rather, at least some of the above findings can now be
explained by the secondary effects on phosphorylation of
Ser-120 and Ser-123. The failure of SV677 to bind to site I
might also be due to its defect in oligomenzation (39a),
because this site is preferentially bound by oligomeric forms
of LT (13). In conclusion, both phosphorylation domains
seem to regulate the DNA-binding and replication functions
of LT in a concerted fashion.
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